Cargando…
Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation
BACKGROUND: Low-voltage-substrate (LVS)-guided ablation for persistent atrial fibrillation (AF) has been described either in sinus rhythm (SR) or AF. Prolonged fractionated potentials (PFPs) may represent arrhythmogenic slow conduction substrate and potentially co-localize with LVS. We assess the sp...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622778/ https://www.ncbi.nlm.nih.gov/pubmed/36330001 http://dx.doi.org/10.3389/fcvm.2022.1000027 |
_version_ | 1784821849826263040 |
---|---|
author | Huang, Taiyuan Chen, Juan Müller-Edenborn, Björn Mayer, Louisa Eichenlaub, Martin Moreno Weidmann, Zoraida Allgeier, Juergen Bohnen, Marius Lehrmann, Heiko Trenk, Dietmar Schoechlin, Simon Westermann, Dirk Arentz, Thomas Jadidi, Amir |
author_facet | Huang, Taiyuan Chen, Juan Müller-Edenborn, Björn Mayer, Louisa Eichenlaub, Martin Moreno Weidmann, Zoraida Allgeier, Juergen Bohnen, Marius Lehrmann, Heiko Trenk, Dietmar Schoechlin, Simon Westermann, Dirk Arentz, Thomas Jadidi, Amir |
author_sort | Huang, Taiyuan |
collection | PubMed |
description | BACKGROUND: Low-voltage-substrate (LVS)-guided ablation for persistent atrial fibrillation (AF) has been described either in sinus rhythm (SR) or AF. Prolonged fractionated potentials (PFPs) may represent arrhythmogenic slow conduction substrate and potentially co-localize with LVS. We assess the spatial correlation of PFP identified in AF (PFP-AF) to those mapped in SR (PFP-SR). We further report the relationship between LVS and PFPs when mapped in AF or SR. MATERIALS AND METHODS: Thirty-eight patients with ablation naïve persistent AF underwent left atrial (LA) high—density mapping in AF and SR prior to catheter ablation. Areas presenting PFP-AF and PFP-SR were annotated during mapping on the LA geometry. Low-voltage areas (LVA) were quantified using a bipolar threshold of 0.5 mV during both AF and SR mapping. Concordance of fractionated potentials (CFP) (defined as the presence of PFPs in both rhythms within a radius of 6 mm) was quantified. Spatial distribution and correlation of PFP and CFP with LVA were assessed. The predictors for CFP were determined. RESULTS: PFPs displayed low voltages both during AF (median 0.30 mV (Q1–Q3: 0.20–0.50 mV) and SR (median 0.35 mV (Q1–Q3: 0.20–0.56 mV). The duration of PFP-SR was measured at 61 ms (Q1–Q3: 51–76 ms). During SR, most PFP-SRs (89.4 and 97.2%) were located within LVA (<0.5 mV and <1.0 mV, respectively). Areas presenting PFP occurred more frequently in AF than in SR (median: 9.5 vs. 8.0, p = 0.005). Both PFP-AF and PFP-SR were predominantly located at anterior LA (>40%), followed by posterior LA (>20%) and septal LA (>15%). The extent of LVA < 0.5 mV was more extensive in AF (median: 25.2% of LA surface, Q1–Q3:16.6–50.5%) than in SR (median: 12.3%, Q1–Q3: 4.7–29.4%, p = 0.001). CFP in both rhythms occurred in 80% of PFP-SR and 59% of PFP-AF (p = 0.008). Notably, CFP was positively correlated to the extent of LVA in SR (p = 0.004), but not with LVA in AF (p = 0.226). Additionally, the extent of LVA < 0.5 mV in SR was the only significant predictor for CFP, with an optimal threshold of 16% predicting high (>80%) fractionation concordance in AF and SR. CONCLUSION: Substrate mapping in SR vs. AF reveals smaller areas of low voltage and fewer sites with PFP. PFP-SR are located within low-voltage areas in SR. There is a high degree of spatial agreement (80%) between PFP-AF and PFP-SR in patients with moderate LVA in SR (>16% of LA surface). These findings should be considered when substrate-based ablation strategies are applied in patients with the left atrial low-voltage substrate with recurrent persistent AF. |
format | Online Article Text |
id | pubmed-9622778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96227782022-11-02 Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation Huang, Taiyuan Chen, Juan Müller-Edenborn, Björn Mayer, Louisa Eichenlaub, Martin Moreno Weidmann, Zoraida Allgeier, Juergen Bohnen, Marius Lehrmann, Heiko Trenk, Dietmar Schoechlin, Simon Westermann, Dirk Arentz, Thomas Jadidi, Amir Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Low-voltage-substrate (LVS)-guided ablation for persistent atrial fibrillation (AF) has been described either in sinus rhythm (SR) or AF. Prolonged fractionated potentials (PFPs) may represent arrhythmogenic slow conduction substrate and potentially co-localize with LVS. We assess the spatial correlation of PFP identified in AF (PFP-AF) to those mapped in SR (PFP-SR). We further report the relationship between LVS and PFPs when mapped in AF or SR. MATERIALS AND METHODS: Thirty-eight patients with ablation naïve persistent AF underwent left atrial (LA) high—density mapping in AF and SR prior to catheter ablation. Areas presenting PFP-AF and PFP-SR were annotated during mapping on the LA geometry. Low-voltage areas (LVA) were quantified using a bipolar threshold of 0.5 mV during both AF and SR mapping. Concordance of fractionated potentials (CFP) (defined as the presence of PFPs in both rhythms within a radius of 6 mm) was quantified. Spatial distribution and correlation of PFP and CFP with LVA were assessed. The predictors for CFP were determined. RESULTS: PFPs displayed low voltages both during AF (median 0.30 mV (Q1–Q3: 0.20–0.50 mV) and SR (median 0.35 mV (Q1–Q3: 0.20–0.56 mV). The duration of PFP-SR was measured at 61 ms (Q1–Q3: 51–76 ms). During SR, most PFP-SRs (89.4 and 97.2%) were located within LVA (<0.5 mV and <1.0 mV, respectively). Areas presenting PFP occurred more frequently in AF than in SR (median: 9.5 vs. 8.0, p = 0.005). Both PFP-AF and PFP-SR were predominantly located at anterior LA (>40%), followed by posterior LA (>20%) and septal LA (>15%). The extent of LVA < 0.5 mV was more extensive in AF (median: 25.2% of LA surface, Q1–Q3:16.6–50.5%) than in SR (median: 12.3%, Q1–Q3: 4.7–29.4%, p = 0.001). CFP in both rhythms occurred in 80% of PFP-SR and 59% of PFP-AF (p = 0.008). Notably, CFP was positively correlated to the extent of LVA in SR (p = 0.004), but not with LVA in AF (p = 0.226). Additionally, the extent of LVA < 0.5 mV in SR was the only significant predictor for CFP, with an optimal threshold of 16% predicting high (>80%) fractionation concordance in AF and SR. CONCLUSION: Substrate mapping in SR vs. AF reveals smaller areas of low voltage and fewer sites with PFP. PFP-SR are located within low-voltage areas in SR. There is a high degree of spatial agreement (80%) between PFP-AF and PFP-SR in patients with moderate LVA in SR (>16% of LA surface). These findings should be considered when substrate-based ablation strategies are applied in patients with the left atrial low-voltage substrate with recurrent persistent AF. Frontiers Media S.A. 2022-10-18 /pmc/articles/PMC9622778/ /pubmed/36330001 http://dx.doi.org/10.3389/fcvm.2022.1000027 Text en Copyright © 2022 Huang, Chen, Müller-Edenborn, Mayer, Eichenlaub, Moreno Weidmann, Allgeier, Bohnen, Lehrmann, Trenk, Schoechlin, Westermann, Arentz and Jadidi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Huang, Taiyuan Chen, Juan Müller-Edenborn, Björn Mayer, Louisa Eichenlaub, Martin Moreno Weidmann, Zoraida Allgeier, Juergen Bohnen, Marius Lehrmann, Heiko Trenk, Dietmar Schoechlin, Simon Westermann, Dirk Arentz, Thomas Jadidi, Amir Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation |
title | Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation |
title_full | Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation |
title_fullStr | Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation |
title_full_unstemmed | Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation |
title_short | Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—A high-density mapping study in persistent atrial fibrillation |
title_sort | validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm—a high-density mapping study in persistent atrial fibrillation |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622778/ https://www.ncbi.nlm.nih.gov/pubmed/36330001 http://dx.doi.org/10.3389/fcvm.2022.1000027 |
work_keys_str_mv | AT huangtaiyuan validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT chenjuan validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT mulleredenbornbjorn validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT mayerlouisa validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT eichenlaubmartin validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT morenoweidmannzoraida validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT allgeierjuergen validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT bohnenmarius validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT lehrmannheiko validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT trenkdietmar validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT schoechlinsimon validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT westermanndirk validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT arentzthomas validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation AT jadidiamir validatingleftatrialfractionationandlowvoltagesubstrateduringatrialfibrillationandsinusrhythmahighdensitymappingstudyinpersistentatrialfibrillation |